Amadeus Capital Partners news and market signals

Spanish molecular diagnostics firm iPremom has closed a, 15 million seed funding round to accelerate the clinical validation of its MaiRa platform. This capital injection aims to transition the company from research to commercial rollout by targeting early indicators of pregnancy complications through blood-based testing.